No randomised, placebo-controlled, peer-reviewed full paper exists
The compound appears to normalize this ratio, helping clear debris without allowing runaway tissue degradation
The available evidence consists primarily of animal studies and limited early-phase human trials, with no published phase III clinical trial data demonstrating efficacy in inflammatory bowel disease (IBD).[1][2] The literature describes BPC-157 as a stable gastric pentadecapeptide that was tested in phase II clinical trials for inflammatory bowel disease (referenced as PL 14736), with reports indicating it was "safe" and had "no side effects." However, a 2025 review emphasizes that BPC-157 "has not been approved for use in standard medicine by the FDA and other global regulatory authorities due to the absence of sufficient and comprehensive clinical studies confirming its health benefits in humans."[1][3][2] The preclinical evidence is extensive but limited to animal models
Together, they decrease levels of TNF-, IL-6, and CRP, preventing chronic inflammation and promoting a stable biochemical environment for regeneration and repair
One should try to keep the blisters intact as long as possible to aid in the healing process
Retinol or chemical peels (with physician supervision and Rx strength) can be used to tighten and thicken skin in the under-eye area, and these strong resurfacing chemicals are really the only skincare products that can reverse damage in this area